Overview

Join us for a dynamic and comprehensive symposium where we will dive into the latest best practices and tackle key controversies across medical, surgical, reconstructive, and radiation oncology. You’ll also explore essential topics like survivorship and supportive care, gaining practical strategies you can immediately implement in your clinical practice. Stay ahead of the curve with insights into this year’s most significant advancements and a sneak peek at groundbreaking therapies on the horizon. This is your opportunity to enhance outcomes for all breast cancer subtypes and empower long-term survivors, as we navigate the future of breast cancer care together.

Learning Objectives

After this activity, participants will be able to:

• Identify the principles of breast cancer survivorship;
• Discuss changes in surgical management of breast cancer including de-escalation of axillary surgery;
• Illustrate how the latest key research findings can be applied to improve clinical care and treatment strategies for patients with breast cancer;
• Describe how to manage common toxicities of novel therapies for breast cancer, including antibody-drug conjugates and novel endocrine therapies;
• Evaluate the scientific rationale and patient population of ongoing, relevant clinical trials in breast cancer.

Target Audience

This activity is designed for physicians and other healthcare professionals caring for patients with breast cancer.

Accreditation

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.